Forma Therapeutics Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2021
August 13, 2021 at 07:05 am EDT
Forma Therapeutics Holdings, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported loss from operations of $44,058,000 against $26,939,000 a year ago. Net loss was $43,585,000 against $25,440,000 a year ago. Net loss per basic and diluted share was $0.92 against $4.58 a year ago.
For the six months, the company reported loss from operations of $80,268,000 against $59,165,000 a year ago. Net loss was $79,545,000 against $14,210,000 a year ago. Net loss per basic and diluted share was $1.68 against $4.23 a year ago.